These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 22013172)

  • 1. Collaborative ocular melanoma study randomized trial of I-125 brachytherapy.
    Hawkins BS
    Clin Trials; 2011 Oct; 8(5):661-73. PubMed ID: 22013172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ten-year follow-up of fellow eyes of patients enrolled in Collaborative Ocular Melanoma Study randomized trials: COMS report no. 22.
    Collaborative Ocular Melanoma Study Group
    Ophthalmology; 2004 May; 111(5):966-76. PubMed ID: 15121376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
    Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
    Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of survival among eligible patients not enrolled versus enrolled in the Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma.
    Gilson MM; Diener-West M; Hawkins BS
    Ophthalmic Epidemiol; 2007; 14(4):251-7. PubMed ID: 17896305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24.
    Hawkins BS;
    Am J Ophthalmol; 2004 Dec; 138(6):936-51. PubMed ID: 15629284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life after iodine 125 brachytherapy vs enucleation for choroidal melanoma: 5-year results from the Collaborative Ocular Melanoma Study: COMS QOLS Report No. 3.
    Melia M; Moy CS; Reynolds SM; Hayman JA; Murray TG; Hovland KR; Earle JD; Kurinij N; Dong LM; Miskala PH; Fountain C; Cella D; Mangione CM;
    Arch Ophthalmol; 2006 Feb; 124(2):226-38. PubMed ID: 16476893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative dose for choroidal melanoma treated with an iodine-125 radioactive plaque: a single-institution retrospective study.
    Saconn PA; Gee CJ; Greven CM; McCoy TP; Ekstrand KE; Greven KM
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):844-8. PubMed ID: 20171804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
    Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
    Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of cataract and outcomes after cataract surgery in the first 5 years after iodine 125 brachytherapy in the Collaborative Ocular Melanoma Study: COMS Report No. 27.
    Collaborative Ocular Melanoma Study Group
    Ophthalmology; 2007 Jul; 114(7):1363-71. PubMed ID: 17337065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18.
    Diener-West M; Earle JD; Fine SL; Hawkins BS; Moy CS; Reynolds SM; Schachat AP; Straatsma BR;
    Arch Ophthalmol; 2001 Jul; 119(7):969-82. PubMed ID: 11448319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19.
    Jampol LM; Moy CS; Murray TG; Reynolds SM; Albert DM; Schachat AP; Diddie KR; Engstrom RE; Finger PT; Hovland KR; Joffe L; Olsen KR; Wells CG;
    Ophthalmology; 2002 Dec; 109(12):2197-206. PubMed ID: 12466159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival in choroidal and ciliary body melanoma after enucleation versus plaque radiation therapy.
    Augsburger JJ; Corrêa ZM; Freire J; Brady LW
    Ophthalmology; 1998 Sep; 105(9):1670-8. PubMed ID: 9754176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma: IV. Local Treatment Failure and Enucleation in the First 5 Years after Brachytherapy. COMS Report No. 19.
    Jampol LM; Moy CS; Murray TG; Reynolds SM; Albert DM; Schachat AP; Diddie KR; Engstrom RE; Finger PT; Hovland KR; Joffe L; Olsen KR; Wells CG;
    Ophthalmology; 2020 Apr; 127(4S):S148-S157. PubMed ID: 32200815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term Results of the UCSF-LBNL Randomized Trial: Charged Particle With Helium Ion Versus Iodine-125 Plaque Therapy for Choroidal and Ciliary Body Melanoma.
    Mishra KK; Quivey JM; Daftari IK; Weinberg V; Cole TB; Patel K; Castro JR; Phillips TL; Char DH
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):376-83. PubMed ID: 25841624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28.
    Collaborative Ocular Melanoma Study Group
    Arch Ophthalmol; 2006 Dec; 124(12):1684-93. PubMed ID: 17159027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 17-year retrospective study of institutional results for eye plaque brachytherapy of uveal melanoma using (125)I, (103)Pd, and (131)Cs and historical perspective.
    Leonard KL; Gagne NL; Mignano JE; Duker JS; Bannon EA; Rivard MJ
    Brachytherapy; 2011; 10(4):331-9. PubMed ID: 21349775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings. COMS report no. 10.
    Am J Ophthalmol; 1998 Jun; 125(6):779-96. PubMed ID: 9645716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
    Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
    Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.